Systemic Therapy in Renal Cell Carcinoma: Advancing Paradigms Cancer Network It is recognized that early intervention with nephrectomy results in excellent long-term survival. In 2005, the US Food and Drug Administration (FDA) approved the first small molecule therapy for kidney cancer, sorafenib (Nexavar). |
